GlaxoSmithKline S.A.E (EGX:BIOC)

Market Cap	6.08B +89.4%
Revenue (ttm)	3.73B +24.7%
Net Income	213.23M +22.6%
EPS	2.55 +22.6%
Shares Out	83.51M
PE Ratio	28.50
Forward PE	n/a
Dividend	1.00 (1.37%)
Ex-Dividend Date	Jan 12, 2026

Volume	26,871
Open	73.88
Previous Close	73.88
Day's Range	71.90 - 74.00
52-Week Range	34.34 - 81.50
Beta	0.81
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 1, 2026

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E was founded in 1981 and is based in New Cairo, Egypt. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 800
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: BIOC

Financial Performance

In 2025, GlaxoSmithKline S.A.E's revenue was 3.73 billion, an increase of 24.73% compared to the previous year's 2.99 billion. Earnings were 213.23 million, an increase of 22.56%.